Sinopharm is consistent: Profit prediction compensation agreement between Shanghai Hyundai Pharmaceutical Co., Ltd. and the company to issue shares to purchase assets (1)

SZSI · May 31, 2016 08:04

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.